Recently, an efflux function of OCT1 for IBC was proposed (Kim et al., 2017) based on transport experiments with mOCT1 and the relationship between human plasma carnitine derivatives and human OCT1 genotype was explained by that finding with murine OCT1. Here, SLC22A1 is linked to inflammatory breast carcinoma.